Skip to main content
. 2022 Jan 28;58(2):203. doi: 10.3390/medicina58020203

Table 12.

Assessment of RANTES and PD-L1 expression in TILs.

n %
RANTES-positive cells in TILs 0–5% 7 29.17
6–25% 3 12.50
26–50% 8 33.33
51–75% 4 16.67
>75% 2 8.33
PD-L1-positive cells in TILs 0–5% 9 18.37
6–25% 7 14.29
26–50% 5 10.20
51–75% 1 2.04
>75% 2 4.08